ArticleFrontiers in immunology2025

FCGR2A defines prognostic immune subtypes and drives tumor progression in hepatocellular carcinoma.

Deyuan Zhong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.